Literature DB >> 10841510

Angiotensin II, atherosclerosis, and aortic aneurysms.

B C Berk1, J Haendeler, J Sottile.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841510      PMCID: PMC300860          DOI: 10.1172/JCI9820

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms.

Authors:  Y Moriguchi; H Matsubara; Y Mori; S Murasawa; H Masaki; K Maruyama; Y Tsutsumi; Y Shibasaki; Y Tanaka; T Nakajima; K Oda; T Iwasaka
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

4.  MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.

Authors:  R W Thompson; B T Baxter
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

5.  Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury.

Authors:  M F Prescott; W K Sawyer; J Von Linden-Reed; M Jeune; M Chou; S L Caplan; A Y Jeng
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

6.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

7.  Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis.

Authors:  P E Tummala; X L Chen; C L Sundell; J B Laursen; C P Hammes; R W Alexander; D G Harrison; R M Medford
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

8.  Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.

Authors:  J Esparza; C Vilardell; J Calvo; M Juan; J Vives; A Urbano-Márquez; J Yagüe; M C Cid
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

9.  Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms.

Authors:  J A Curci; S Liao; M D Huffman; S D Shapiro; R W Thompson
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

10.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

View more
  17 in total

1.  When it is inflamed, it hurts.

Authors:  R Baliga; J Narula
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model.

Authors:  K Gopal; Kishor Kumar; R Nandini; P Jahan; M J Mahesh Kumar
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 3.  Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors:  Dorrin Zarrin Khat; Mansoor Husain
Journal:  Curr Diab Rep       Date:  2018-06-09       Impact factor: 4.810

4.  Parsing aortic aneurysms: more surprises.

Authors:  Mark W Majesky; Xiu Rong Dong; Virginia J Hoglund
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

5.  Peroxisome proliferator-activated receptor γ coactivator-1α is a central negative regulator of vascular senescence.

Authors:  Shiqin Xiong; Gloria Salazar; Nikolay Patrushev; Minhui Ma; Farshad Forouzandeh; Lula Hilenski; R Wayne Alexander
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

6.  Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries.

Authors:  Mitsuru Ohishi; Gregory J Dusting; Paul A Fennessy; Frederick Ao Mendelsohn; Xiao C Li; Jia L Zhuo
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-04-30

7.  GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells.

Authors:  Jinjiang Pang; Chen Yan; Kanchana Natarajan; Megan E Cavet; Michael P Massett; Guoyong Yin; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

8.  Expression of G-protein subunit α-14 is increased in human placentas from preeclamptic pregnancies.

Authors:  Ying-Jie Zhao; Qing-Yun Zou; Yan Li; Hui-Hui Li; Yan-Ming Wu; Xing-Fu Li; Kai Wang; Jing Zheng
Journal:  J Histochem Cytochem       Date:  2014-01-14       Impact factor: 2.479

Review 9.  Role of oxygen in fetoplacental endothelial responses: hypoxia, physiological normoxia, or hyperoxia?

Authors:  Chi Zhou; Qing-Yun Zou; Yi-Zhou Jiang; Jing Zheng
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-08       Impact factor: 4.249

Review 10.  Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand.

Authors:  Toshimasa Itoh; Keiko Yamamoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.